<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Contrast Enhanced Liver MRI in Patients with Primary Sclerosing Cholangitis" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/contrast-enhanced-liver-mri-in-patients-with-primary-sclerosing-cholangitis/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/contrast-enhanced-liver-mri-in-patients-with-primary-sclerosing-cholangitis/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2011-11-30T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Contrast Enhanced Liver MRI in Patients with Primary Sclerosing Cholangitis" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2011-11-30T17:00:00+00:00","description":"Rationale and Objectives","headline":"Contrast Enhanced Liver MRI in Patients with Primary Sclerosing Cholangitis","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/contrast-enhanced-liver-mri-in-patients-with-primary-sclerosing-cholangitis/"},"url":"https://clinicaltree.github.io/posts/contrast-enhanced-liver-mri-in-patients-with-primary-sclerosing-cholangitis/"}</script><title>Contrast Enhanced Liver MRI in Patients with Primary Sclerosing Cholangitis | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Contrast Enhanced Liver MRI in Patients with Primary Sclerosing Cholangitis</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Contrast Enhanced Liver MRI in Patients with Primary Sclerosing Cholangitis</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1322672400" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Nov 30, 2011 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Daniela B. Husarik MD</a> </em>, <em> <a href="">Rajan T. Gupta MD</a> </em>, <em> <a href="">Kristina I. Ringe MD</a> </em>, <em> <a href="">Daniel T. Boll MD</a> </em>, <em> <a href="">Elmar M. Merkle MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1555 words"> <em>8 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>To assess the enhancement pattern of focal confluent fibrosis (FCF) on contrast-enhanced hepatic magnetic resonance imaging (MRI) using hepatocyte-specific (Gd-EOB-DTPA) and extracellular (ECA) gadolinium-based contrast agents in patients with primary sclerosing cholangitis (PSC).</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>After institutional review board approval, 10 patients with PSC (6 male, 4 female; 33–61 years) with 13 FCF were included in this retrospective study. All patients had a Gd-EOB-DTPA–enhanced liver MRI exam, and a comparison ECA-enhanced MRI. On each T1-weighted dynamic dataset, the signal intensity (SI) of FCF and the surrounding liver as well as the paraspinal muscle (M) were measured. In the Gd-EOB-DTPA group, hepatocyte phase images were also included. SI FCF/SI M, SI liver/SI M, and [(SI liver − SI FCF)/SI liver] were compared between the different contrast agents for each dynamic phase using the paired Student’s <em>t</em> -test.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>There was no significant difference in SI FCF/SI M in all imaging phases. SI liver/SI M was significantly higher for the Gd-EOB-DTPA group in the delayed phase ( <em>P</em> &lt; .001), whereas there was no significant difference in all other imaging phases. In the Gd-EOB-DTPA group, mean [(SI liver − SI FCF)/SI liver] were as follows (values for ECA group in parentheses): unenhanced phase: 0.26 (0.26); arterial phase: 0.01 (−0.31); portal venous phase (PVP): −0.05 (−0.26); delayed phase (DP): 0.14 (−0.54); and hepatocyte phase: 0.26. Differences were significant for the DP ( <em>P</em> &lt; .001).</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>On delayed phase MR images the FCF-to-liver contrast is reversed with the lesions appearing hyperintense on ECA enhanced images and hypointense on Gd-EOB-DTPA–enhanced images.</p><p>Primary sclerosing cholangitis (PSC), a chronic cholestatic liver disease of unknown cause, is characterized by fibrosing inflammatory destruction of the bile ducts, subsequent hepatic fibrosis, and ultimately cirrhosis . In patients with PSC, peripheral wedge-shaped areas of parenchymal atrophy, also called confluent hepatic fibrosis or focal confluent fibrosis (FCF) , have been described in up to 72%; these focal confluent fibrotic lesions typically show hypoenhancement on computed tomography (CT) and magnetic resonance (MR) images obtained immediately after administration of iodinated CT or extracellular gadolinium-based MR contrast agents and hyperenhancement on delayed phase images . Because these FCF are oftentimes mildly hyperintense on T2-weighted (T2w) MR imaging, they are among the most relevant differential considerations for hepatocellular carcinoma and cholangiocarcinoma.</p><p>To the best of our knowledge, the enhancement pattern of FCF on fat saturated dynamic T1w MR imaging performed after administration of GD-EOB-DTPA (gadoxetate disodium, Eovist/Primovist, Bayer HealthCare Pharmaceuticals Inc, Wayne, NJ) has not been described yet. Therefore, this study was performed to assess the enhancement pattern of focal confluent fibrosis on contrast-enhanced hepatic MR imaging using hepatocyte-specific (Gd-EOB-DTPA) and extracellular (ECA) gadolinium-based contrast agents in patients with PSC.</p><h2 id="material-and-methods"><span class="mr-2">Material and methods</span><a href="#material-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-population"><span class="mr-2">Study Population</span><a href="#study-population" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="quantitative-analysis"><span class="mr-2">Quantitative Analysis</span><a href="#quantitative-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Onset of the Various Data Acquisition Phases Derived from the DICOM Header</p><p>Contrast Phase Arterial</p><p>Mean ± SD Portal Venous</p><p>Mean ± SD Delayed</p><p>Mean ± SD Hepatocyte</p><p>Mean ± SD Gd-EOB-DTPA 24 seconds ± 2 seconds 62 seconds ± 19 seconds 7 minutes, 38 seconds ± 2 minutes 20 minutes, 19 seconds ± 6 minutes, 26 seconds Extracellular CA 24 seconds ± 4 seconds 68 seconds ± 14 seconds 7 minutes, 32 seconds ± 2 minutes, 32 seconds_P_ value .78 .41 .89</p><p>Values represent the beginning of the pulse sequence data acquisition after the initiation of contrast administration. <em>P</em> values are calculated using a paired Student’s <em>t</em> -test.</p><p>CA, contrast agent; mean, average value based on a sample size of ten patients; Gd-EOB-DTPA, hepatocyte-specific gadolinium; SD, standard deviation of the mean.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Ratios of the Signal Intensity Values of Focal Fibrotic Lesions and Surrounding Liver to the Signal Intensity Values of the Paraspinal Muscle, and Focal Fibrotic Lesion-to-liver Ratios for the Various Contrast Phases for the Two Different Contrast Agent Groups</p><p>Unenhanced Mean ± SD Min–Max Arterial Mean ± SD Min–Max Portal Venous Mean ± SD Min–Max Delayed</p><p>Mean ± SD</p><p>Min–Max Hepatocyte</p><p>Mean ± SD</p><p>Min–Max SI FCF/SI M Gd-EOB-DTPA 0.73 ± 0.27</p><p>0.38–1.25 1.06 ± 0.48</p><p>0.5–2.07 1.35 ± 0.52</p><p>0.75–2.32 1.36 ± 0.41</p><p>0.73–1.99 1.18 ± 0.41</p><p>0.56–1.87 Extracellular contrast agent 0.65 ± 0.24</p><p>0.39–1.24 1.46 ± 0.60</p><p>0.70–2.80 1.80 ± 0.92</p><p>0.50–3.67 1.59 ± 0.53</p><p>1.01–2.51 —<em>P</em> value .42 .07 .14 .23 SI liver/SI M Gd-EOB-DTPA 1.00 ± 0.33</p><p>0.47–1.73 1.08 ± 0.32</p><p>0.63–1.51 1.28 ± 0.28</p><p>0.89–1.75 1.62 ± 0.35</p><p>0.94–2.10 1.64 ± 0.46</p><p>0.97–2.34 Extracellular contrast agent 0.93 ± 0.45</p><p>0.59–1.98 1.28 ± 0.77</p><p>0.54–3.31 1.44 ± 0.44</p><p>0.78–2.20 1.05 ± 0.33</p><p>0.63–1.85 —<em>P</em> Value .67 .40 .28 &lt;.001 [(SI Liver–SI FCF)/SI Liver] Gd-EOB-DTPA 0.26 ± 0.14</p><p>0.08–0.59 0.01 ± 0.37</p><p>−0.91–0.45 −0.05 ± 0.30</p><p>−0.47–0.82 0.14 ± 0.26</p><p>−0.50–0.61 0.26 ± 0.24</p><p>−0.374–0.70 Extracellular contrast agent 0.26 ± 0.18</p><p>0.02–0.68 −0.31 ± 0.49</p><p>−0.90–0.65 −0.26 ± 0.50</p><p>−0.85–0.70 −0.54 ± 0.35</p><p>−1.12–−0.16<em>P</em> value 0.89 0.08 0.21 &lt;0.001</p><p><em>P</em> values are derived from the paired Student’s <em>t</em> -test.</p><p>FCF, focal fibrotic lesion; M, paraspinal muscle; mean, average value based on a sample size of 13 focal fibrotic lesions; max, maximum value of the 13 focal fibrotic lesions; SD, standard deviation of the mean; min, minimum value of the 13 focal fibrotic lesions; SI, signal intensity.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ContrastEnhancedLiverMRIinPatientswithPrimarySclerosingCholangitis/0_1s20S1076633211003941.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ContrastEnhancedLiverMRIinPatientswithPrimarySclerosingCholangitis/0_1s20S1076633211003941.jpg" alt="Figure 1, A 34-year-old male patient with known primary sclerosing cholangitis and normal liver function tests (total bilirubin 0.9 mg/dL [0.1–1.5 mg/dL]). Focal liver lesion is stable over the time course of 2 years. Hepatocyte-specific gadolinium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging. (a) On the axial three-dimensional (3D) gradient echo fat-suppressed Ti-weighted (T1w) image, the focal fibrotic lesion (FCF, arrow ) appears hypointense to the surrounding liver. Axial fat-suppressed 3D T1w gradient echo dynamic datasets acquired after the administration of 10 mL Gd-EOB-DTPA, demonstrate (b) the initial increase of the contrast-to-noise ratio (CNR) of the FCF ( arrow ) and the surrounding liver in the arterial phase, (c) and the portal venous phase, followed by (d) a decrease of the CNR in the delayed and (e) hepatocyte-specific phase. The corresponding (gadobenate dimeglumine) Gd-BOPTA enhanced comparison study was performed 14 months before the Gd-EOB-DTPA study. (f) On the axial 3D gradient echo fat suppressed T1w image, the FCF ( arrow ) again appears hypointense to the surrounding liver. After the administration of 20 mL of Gd-BOPTA, axial fat suppressed 3D T1w gradient echo dynamic datasets were acquired. (g) The FCF ( arrow ) enhances in the arterial phase, and the CNR continues to raise in (h) the portal venous phase, and (i) the delayed phase." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ContrastEnhancedLiverMRIinPatientswithPrimarySclerosingCholangitis/1_1s20S1076633211003941.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ContrastEnhancedLiverMRIinPatientswithPrimarySclerosingCholangitis/1_1s20S1076633211003941.jpg" alt="Figure 2, A 54-year-old female patient with primary sclerosing cholangitis and normal liver function tests (total bilirubin 0.7 mg/dL [0.1–1.5 mg/dL]). Focal liver lesion is stable over the time course of 6 years; percutaneous biopsy revealed focal fibrosis. Hepatocyte-specific gadolinium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging. (a) On the axial three-dimensional (3D) gradient echo fat suppressed T1-weighted (T1w) image, the focal fibrotic lesion (FCF, arrow ) appears hypointense to the surrounding liver. Axial fat suppressed 3D T1w gradient echo dynamic datasets acquired after the administration of 10 mL Gd-EOB-DTPA during the arterial phase (b) , the portal venous phase (c) , the delayed phase (d) , and the hepatocyte-specific phase (e) . Note the hypointense appearance of the FCF ( arrow ) during all contrast-enhanced phases. (The corresponding Gd-BOPTA enhanced comparison study was performed 12 months before the Gd-EOB-DTPA study. (f) On the axial 3D gradient echo fat suppressed T1w image, the FCF ( arrow ) again appears hypointense to the surrounding liver. After the administration of 13 mL of Gd-BOPTA, axial fat suppressed 3D T1w gradient echo dynamic datasets were acquired: arterial phase (g) , portal venous phase (h) , and delayed phase (i) . Note the hyperintense appearance of the FCF ( arrow ) on the delayed phase." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ContrastEnhancedLiverMRIinPatientswithPrimarySclerosingCholangitis/2_1s20S1076633211003941.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ContrastEnhancedLiverMRIinPatientswithPrimarySclerosingCholangitis/2_1s20S1076633211003941.jpg" alt="Figure 3, A 52-year-old female patient with known primary sclerosing cholangitis and impaired liver function (total bilirubin 4.9 mg/dL [0.1–1.5 mg/dL]). (a) Fat-suppressed three-dimensional T1-weighted (T1w) gradient echo image acquired in the hepatocyte specific phase after administration of 10 mL hepatocyte-specific gadolinium (Gd-EOB-DTPA) demonstrates hyperintense signal of the focal fibrotic lesion (FCF; arrow ) compared to the surrounding liver. (b) The corresponding comparison study was performed 4 months prior to the Gd-EOB-DTPA study. The axial T1w gradient echo image acquired in the delayed phase after administration of 20 mL Gd-DTPA-BMA also demonstrates hyperintense signal of the FCF ( arrow ) compared to the surrounding liver. Note that chemical fat suppression failed in this comparison study." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="limitations"><span class="mr-2">Limitations</span><a href="#limitations" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Lee Y.M., Kaplan M.M.: Primary sclerosing cholangitis. N Engl J Med 1995; 332: pp. 924-933.</p><li><p>2. Blachar A., Federle M.P., Sosna J.: Liver lesions with hepatic capsular retraction. Semin Ultrasound CT MR 2009; 30: pp. 426-435.</p><li><p>3. Brancatelli G., Baron R.L., Federle M.P., et. al.: Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT. AJR Am J Roentgenol 2009; 192: pp. 1341-1347.</p><li><p>4. Ohtomo K., Baron R.L., Dodd G.D., et. al.: Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT. Radiology 1993; 188: pp. 31-35.</p><li><p>5. Bader T.R., Beavers K.L., Semelka R.C.: MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology 2003; 226: pp. 675-685.</p><li><p>6. Ohtomo K., Baron R.L., Dodd G.D., et. al.: Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology 1993; 189: pp. 871-874.</p><li><p>7. Revelon G., Rashid A., Kawamoto S., et. al.: Primary sclerosing cholangitis: MR imaging findings with pathologic correlation. AJR Am J Roentgenol 1999; 173: pp. 1037-1042.</p><li><p>8. Valls C., Guma A., Puig I., et. al.: Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 2000; 25: pp. 490-496.</p><li><p>9. Zizka J., Klzo L., Ferda J., et. al.: Dynamic and delayed contrast enhancement in upper abdominal MRI studies: comparison of gadoxetic acid and gadobutrol. Eur J Radiol 2007; 62: pp. 186-191.</p><li><p>10. Rohrer M., Bauer H., Mintorovitch J., et. al.: Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40: pp. 715-724.</p><li><p>11. Schuhmann-Giampieri G., Schmitt-Willich H., Press W.R., et. al.: Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183: pp. 59-64.</p><li><p>12. Park Y., Kim S.H., Jeon Y.H., et. al.: Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience. Korean J Radiol 2010; 11: pp. 433-440.</p><li><p>13. Reimer P., Schneider G., Schima W.: Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 2004; 14: pp. 559-578.</p><li><p>14. Murakami T., Baron R.L., Federle M.P., et. al.: Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 1996; 198: pp. 567-572.</p><li><p>15. Motosugi U., Ichikawa T., Sou H., et. al.: Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?. J Magn Reson Imaging 2009; 30: pp. 1042-1046.</p><li><p>16. Zech C.J., Grazioli L., Breuer J., et. al.: Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 2008; 43: pp. 504-511.</p><li><p>17. Brody J.M., Schafer L., Tung G.A., et. al.: Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid. J Magn Reson Imaging 2005; 21: pp. 391-397.</p><li><p>18. Huppertz A., Haraida S., Kraus A., et. al.: Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT— initial observations. Radiology 2005; 234: pp. 468-478.</p><li><p>19. Soher B.J., Dale B.M., Merkle E.M.: A review of MR physics: 3T versus 1.5T. Magn Reson Imaging Clin N Am 2007; 15: pp. 277-290.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-18/'>Volume 18</a>, <a href='/categories/issue-12/'>Issue 12</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Contrast%20Enhanced%20Liver%20MRI%20in%20Patients%20with%20Primary%20Sclerosing%20Cholangitis%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcontrast-enhanced-liver-mri-in-patients-with-primary-sclerosing-cholangitis%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Contrast%20Enhanced%20Liver%20MRI%20in%20Patients%20with%20Primary%20Sclerosing%20Cholangitis%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcontrast-enhanced-liver-mri-in-patients-with-primary-sclerosing-cholangitis%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcontrast-enhanced-liver-mri-in-patients-with-primary-sclerosing-cholangitis%2F&text=Contrast%20Enhanced%20Liver%20MRI%20in%20Patients%20with%20Primary%20Sclerosing%20Cholangitis%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-margin-sharpness-measurement-for-the-diagnosis-of-breast-cancer-from-magnetic-resonance-imaging-ex/"><div class="card-body"> <em class="small" data-ts="1322672400" data-df="ll" > Nov 30, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Margin Sharpness Measurement for the Diagnosis of Breast Cancer from Magnetic Resonance Imaging Examinations</h3><div class="text-muted small"><p> Rationale and Objectives Cancer screening by magnetic resonance imaging (MRI) has been shown to be one of the most sensitive methods available for the early detection of breast cancer. There is hi...</p></div></div></a></div><div class="card"> <a href="/posts/a-meta-analysis-of-64-section-coronary-ct-angiography-findings-for-predicting-30-day-major-adverse-c/"><div class="card-body"> <em class="small" data-ts="1322672400" data-df="ll" > Nov 30, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Meta-analysis of 64-section Coronary CT Angiography Findings for Predicting 30-day Major Adverse Cardiac Events in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome</h3><div class="text-muted small"><p> Rationale and Objectives To determine the accuracy of 64-section coronary computed tomography angiography (CCTA) in predicting 30 day major adverse cardiac events (MACE) for patients presenting wi...</p></div></div></a></div><div class="card"> <a href="/posts/a-report-on-the-current-status-of-grand-rounds-in-radiology-residency-programs-in-the-united-states/"><div class="card-body"> <em class="small" data-ts="1322672400" data-df="ll" > Nov 30, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Report on the Current Status of Grand Rounds in Radiology Residency Programs in the United States</h3><div class="text-muted small"><p> Rationale and Objectives A national needs assessment of radiology program directors was performed to characterize grand rounds (GR) programs, assess the perceived educational value of GR programs,...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/computer-aided-detection-of-small-pulmonary-nodules-in-chest-radiographs/" class="btn btn-outline-primary" prompt="Older"><p>Computer-aided Detection of Small Pulmonary Nodules in Chest Radiographs</p></a> <a href="/posts/correlation-between-doppler-velocities-and-duplex-ultrasound-carotid-cross-sectional-percent-stenosi/" class="btn btn-outline-primary" prompt="Newer"><p>Correlation between Doppler Velocities and Duplex Ultrasound Carotid Cross-sectional Percent Stenosis</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
